David Gomez Almaguer
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Romiplostim, Rituximab and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia (NCT04588194) | David Gomez Almaguer | 2020-11-01 |
Track David Gomez Almaguer automatically
Every clearance here is in the API, with alerts when new ones post.